You are here : Home ]

News

Kumho Tyres Announced as Official Tyre of the United States Soccer Federation

May 25, 2012

RANCHO CUCAMONGA, Calif. – Kumho Tyre U.S.A. Inc., one of the world’s leading tyre manufacturers, is proud to announce their partnership with the United States Soccer Federation (U.S.S.F.) as the official tyre sponsor of the United States Men’s and Women’s National Soccer teams. Kumho Tyre will be hosting an autograph signing with former star midfielder and current manager for D.C. United, Ben Olsen, prior to the upcoming friendly match between the United States and Brazil on May 30, 2012 at FedEx Field in Landover, Md.
Kumho’s sponsorship of the U.S.S.F. fits well with our national branding campaign that encourages an active and adventurous lifestyle, further highlighted by our ‘Let’s Go’ motto,” said Rick Brennan, vice president of marketing, Kumho Tyre U.S.A. “With the upcoming London Olympics, we are honored to be an official sponsor of United States Soccer.”

INFRARED 800 and FLOW 800 Fluorescence Modules showcased at the EURAPS 2012

The INFRARED 800 and FLOW® 800 fluores- cence modules from medical technology provider Carl Zeiss Meditec enable neurosurgeons to interpret the speed and direction of the blood flow precisely and quickly during surgery. This techno- logy is also available for plastic & reconstructive surgery in the assessment of viable tissue useful in graft surgery. This technological advancement enables surgeons to evaluate tissue grafts per- fusion before transplantation. Vascular occlusions become visible within a few seconds and can be immediately treated intraoperatively.

At the meeting of the European Association of Plastic Surgeons (EURAPS) taking place from May 24 to 28, 2012 in Munich, Germany, Carl Zeiss will present to the medical community this innovative fluorescence technology on its surgical micro- scope platform, OPMI PENTERO® 900.

Initial study results confirm the benefits for plastic and reconstructive surgery

Initial studies have confirmed the benefits of intraoperative fluorescence technology for plastic surgery, in particular for flap grafts.

“The integration of fluorescence technology into the surgical microscope offers the surgeon more safety and certainty in clinically ambiguous si- tuations during the procedure. Blood flow ano- malies can be quickly detected, and the required surgical interventions initiated immediately. The method can predict the complication-free healing of skin and tissue grafts and provide initial indications of thrombosis,” says Prof. Dr. med. Riccardo Giunta of the Ludwig-Maximilians University in Munich, Germany. Dr. Giunta and his colleagues worked with FLOW 800 on the publi- cation titled “Intraoperative indocyanine green fluorescence diagnostics using a surgical microscope in plastic surgery” published in April 2012 in the journal Handchirurgie Microchirurgie Plastische Chirurgie (Holzbach T et al. 2012: Handchir Microchir Plast Chir 44, 84-88).

“We are pleased that we can now expand the fields of application for our fluorescence methods and therefore also assist doctors in plastic and reconstructive surgery in providing their patients with even better treatment,” says Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. “The results of the studies are very promising as they underscore the clinical benefit and innovation potential of the methods for use in different applications.”

Michelin – Leadership through Innovation

May 24, 2012

Michelin intends to remain the leader in tires and mobility assistance by relying on its ability to innovate and the quality of its products.

Ever since Michelin was first set up, the dynamics of innovation and the search for new technologies for the customer’s benefit have been at the core of Michelin’s strategy and success. Its innovations seek to go beyond customers’ expectations and modify the face of future mobility.

To do this, Michelin allocates significant financial and human resources to research and development: R&D has a budget of over 500 million euros and employs over 6,000 people worldwide.

The scope of these activities is very wide, from understanding fundamental chemical and physical phenomena to the production and testing of prototypes, all the way to the feasibility analysis of production on an industrial scale.

The distribution of the research center over three continents ensures familiarity with local usage. It also facilitates external collaboration with the best research laboratories and technical partnerships with industrial companies possessing complementary expertise.

www.michelin.com/corporate/news

dfdfdfdfdf